J Korean Neurosurg Soc.  1996 Mar;25(3):540-543.

BCNU-CDDP Continuous Infusion Chemotherapy in Recurrent Oligodendroglioma

• Youn SM
• Rhee CH
• Lee SH
• Song JW
• Kim JH

Abstract

Eight patients with recurrent oligodendroglioma were treated with 1.3-bis(2-chloroethyl) nitrosourea(BCNU) and CDD continuous infusion chemotherapy. They were 5 with benign oligodendrogliomas and 3 with anaplastic oligodendrogliomas. All the recurrent tumors had been treated with surgery and radiotherapy. Four patients had already received chemotherapy with ACNU. Seven of them showed response to continuous infusion chemotherapy. The time from the response to progression was 15 to 67 weeks. No severe complication of the chemotherapy was found. In conclusion, BCNU-CDDP continuous infusion chemotherapy is an effective treatment modality in recurrent oligodendrogliomas.

Keyword

Oligodendroglioma; Chemotherapy; BCNU; CDDP

MeSH Terms

Carmustine
Drug Therapy*
Humans
Nimustine
Oligodendroglioma*
Radiotherapy
Carmustine
Nimustine